JP2007523139A5 - - Google Patents

Download PDF

Info

Publication number
JP2007523139A5
JP2007523139A5 JP2006553649A JP2006553649A JP2007523139A5 JP 2007523139 A5 JP2007523139 A5 JP 2007523139A5 JP 2006553649 A JP2006553649 A JP 2006553649A JP 2006553649 A JP2006553649 A JP 2006553649A JP 2007523139 A5 JP2007523139 A5 JP 2007523139A5
Authority
JP
Japan
Prior art keywords
base
formula
group
substituted
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006553649A
Other languages
English (en)
Other versions
JP2007523139A (ja
JP4208925B2 (ja
Filing date
Publication date
Priority claimed from GB0403779A external-priority patent/GB0403779D0/en
Priority claimed from GB0420780A external-priority patent/GB0420780D0/en
Application filed filed Critical
Priority claimed from PCT/GB2005/000534 external-priority patent/WO2005080343A2/en
Publication of JP2007523139A publication Critical patent/JP2007523139A/ja
Publication of JP2007523139A5 publication Critical patent/JP2007523139A5/ja
Application granted granted Critical
Publication of JP4208925B2 publication Critical patent/JP4208925B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (1)

  1. 式Iの化合物[式中、Rはa)1以上のフルオロによって置換されたC1〜3アルコキシ基または1以上のフルオロによって置換されていてもよいC4〜6アルコキシ基、またはb)式フェニル(CHO−の基(式中、pは1、2または3であり、そしてフェニル環はZによって表される1、2または3個の基によって置換されていてもよい)、またはc)RS(O)O基を表す]の製造のための方法であって、式IIIの化合物:
    Figure 2007523139
    (式中、R、R、R、R、mおよびnは先に定義した通りである)を
    a)不活性溶媒中、塩基の存在下、−25℃〜150℃の範囲の温度で、式RXのアルキル化剤(式中、Rは1以上のフルオロによって置換されたC1〜3アルキル基または1以上のフルオロによって置換されていてもよいC4〜6アルキル基を表し、そしてXは脱離基を表す);
    b)不活性溶媒中、塩基の存在下、−25℃〜150℃の範囲の温度で、式RXのアルキル化剤(式中、Rは式フェニル(CHO−の基を表し、ここでpは1、2または3であり、フェニル環はZによって表される1、2または3個の基によって置換されていてもよく、そしてXは脱離基を表す);または
    c)不活性溶媒中、塩基の存在下、−25℃〜150℃の範囲の温度で、式RS(O)Lのスルホン化剤(式中、Rは先に定義した通りであり、Lは脱離基を表す);のいずれかとそれぞれ反応させることを含む前記方法。
JP2006553649A 2004-02-20 2005-02-16 治療薬 Expired - Fee Related JP4208925B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0403779A GB0403779D0 (en) 2004-02-20 2004-02-20 Therapeutic agents
GB0420780A GB0420780D0 (en) 2004-09-18 2004-09-18 Therapeutic agents
PCT/GB2005/000534 WO2005080343A2 (en) 2004-02-20 2005-02-16 3-substituted 1,5-diphenylpyrazole derivatives useful as cb1 modulators

Publications (3)

Publication Number Publication Date
JP2007523139A JP2007523139A (ja) 2007-08-16
JP2007523139A5 true JP2007523139A5 (ja) 2008-04-03
JP4208925B2 JP4208925B2 (ja) 2009-01-14

Family

ID=34889139

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006553649A Expired - Fee Related JP4208925B2 (ja) 2004-02-20 2005-02-16 治療薬

Country Status (18)

Country Link
US (1) US20090149463A1 (ja)
EP (1) EP1718617B1 (ja)
JP (1) JP4208925B2 (ja)
KR (1) KR20060131906A (ja)
AR (1) AR047683A1 (ja)
AT (1) ATE440085T1 (ja)
AU (1) AU2005214130B2 (ja)
BR (1) BRPI0507786A (ja)
CA (1) CA2555331C (ja)
DE (1) DE602005016082D1 (ja)
ES (1) ES2329915T3 (ja)
HK (1) HK1095329A1 (ja)
IL (1) IL177218A0 (ja)
NO (1) NO20063787L (ja)
RU (1) RU2375349C2 (ja)
TW (1) TW200531689A (ja)
UY (1) UY28752A1 (ja)
WO (1) WO2005080343A2 (ja)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080146614A1 (en) * 2004-12-23 2008-06-19 Leifeng Cheng Therapeutic Agents
EP1743892A1 (en) * 2005-07-15 2007-01-17 Laboratorios del Dr. Esteve S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
GB0514738D0 (en) * 2005-07-19 2005-08-24 Astrazeneca Ab Therapeutic agents
GB0516661D0 (en) * 2005-08-13 2005-09-21 Astrazeneca Ab Therapeutic agents
AR056560A1 (es) 2005-10-06 2007-10-10 Astrazeneca Ab Pirrolopiridinonas como moduladores cb1
JP5069894B2 (ja) * 2005-10-21 2012-11-07 田辺三菱製薬株式会社 ピラゾール化合物
US7872006B2 (en) 2005-10-21 2011-01-18 Mitsubishi Tanabe Pharma Corporation Pyrazole compounds having cannabinoid receptor (CB1) antagonizing activity
JP2009541283A (ja) * 2006-06-20 2009-11-26 アストラゼネカ アクチボラグ 治療薬
CN101472896A (zh) * 2006-06-20 2009-07-01 阿斯利康(瑞典)有限公司 治疗药剂
RU2009108280A (ru) 2006-08-08 2010-09-20 Санофи-Авентис (Fr) Ариламиноарилалкилзамещенные имидазолидин-2,4-дионы, способы их получения, содержащие эти соединения лекарственные средства и их применение
CA2673359A1 (en) * 2006-12-18 2008-06-26 7Tm Pharma A/S Cb1 receptor modulators
ES2586433T3 (es) 2007-04-11 2016-10-14 Omeros Corporation Composiciones y métodos para la profilaxis y el tratamiento de adicciones
US20160331729A9 (en) 2007-04-11 2016-11-17 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
US11241420B2 (en) 2007-04-11 2022-02-08 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE102008015033A1 (de) 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung
DE102008015032A1 (de) 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte Pyrazolamide und ihre Verwendung
WO2010003624A2 (en) 2008-07-09 2010-01-14 Sanofi-Aventis Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
GB0815134D0 (en) * 2008-08-19 2008-09-24 Univ Aberdeen Therapeutic compounds and their use
WO2010068601A1 (en) 2008-12-08 2010-06-17 Sanofi-Aventis A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
DE102008062878A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte Furancarboxamide und ihre Verwendung
DE102008062863A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung
DE102009036604A1 (de) 2009-07-30 2011-02-03 Aicuris Gmbh & Co. Kg Substituierte Bis-Arylpyrazolamide mit terminaler primärer Amidfunktionalisierung und ihre Verwendung
WO2011023754A1 (en) 2009-08-26 2011-03-03 Sanofi-Aventis Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use
EP2582709B1 (de) 2010-06-18 2018-01-24 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
WO2012120051A1 (de) 2011-03-08 2012-09-13 Sanofi Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2683701B1 (de) 2011-03-08 2014-12-24 Sanofi Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2683702B1 (de) 2011-03-08 2014-12-24 Sanofi Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2012120054A1 (de) 2011-03-08 2012-09-13 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8895547B2 (en) 2011-03-08 2014-11-25 Sanofi Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
US8871758B2 (en) 2011-03-08 2014-10-28 Sanofi Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
US8901114B2 (en) 2011-03-08 2014-12-02 Sanofi Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
EP2683699B1 (de) 2011-03-08 2015-06-24 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2683704B1 (de) 2011-03-08 2014-12-17 Sanofi Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
CN102358735B (zh) * 2011-08-23 2013-09-04 范如霖 低毒性的多头分导药,带羟基或取代羟基的含氮芳环cb1受体抑制剂及其制药用途
DE102011055815A1 (de) 2011-11-29 2013-05-29 Aicuris Gmbh & Co. Kg Carboxamid-substituierte Heteroaryl-Pyrazole und ihre Verwendung
DE102012016908A1 (de) 2012-08-17 2014-02-20 Aicuris Gmbh & Co. Kg Tris-(Hetero)Aryl-Pyrazole und ihre Verwendung
WO2020114813A1 (en) * 2018-12-04 2020-06-11 Basf Se Process for preparation of 5-bromo-1,3-dichloro-2-fluoro-benzene
CN113816892A (zh) * 2021-08-27 2021-12-21 安徽鼎旺医药有限公司 一种醋酸巴多昔芬的合成方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2665898B1 (fr) * 1990-08-20 1994-03-11 Sanofi Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2692575B1 (fr) * 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2714057B1 (fr) * 1993-12-17 1996-03-08 Sanofi Elf Nouveaux dérivés du 3-pyrazolecarboxamide, procédé pour leur préparation et compositions pharmaceutiques les contenant.
FR2732967B1 (fr) * 1995-04-11 1997-07-04 Sanofi Sa 1-phenylpyrazole-3-carboxamides substitues, actifs sur la neurotensine, leur preparation, les compositions pharmaceutiques en contenant
FR2789079B3 (fr) * 1999-02-01 2001-03-02 Sanofi Synthelabo Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant
JP2004502642A (ja) * 2000-02-11 2004-01-29 ブリストル−マイヤーズ スクイブ カンパニー カンナビノイドレセプターモジュレーター、それらの製造方法、および呼吸系および非呼吸系疾患の処置のためのカンナビノイドレセプターモジュレーターの使用
AU2002331766A1 (en) * 2001-08-31 2003-03-18 University Of Connecticut Novel pyrazole analogs acting on cannabinoid receptors
US6825209B2 (en) * 2002-04-15 2004-11-30 Research Triangle Institute Compounds having unique CB1 receptor binding selectivity and methods for their production and use
ES2379076T3 (es) * 2002-12-02 2012-04-20 Astellas Pharma Inc. Derivados de pirazol útiles como inhibidores de COX-I

Similar Documents

Publication Publication Date Title
JP2007523139A5 (ja)
JP2008523069A5 (ja)
JP2010510976A5 (ja)
JP2005289914A5 (ja)
JP2005053931A5 (ja)
JP2010536766A5 (ja)
JP2004002298A5 (ja) オリゴフルオレニレン化合物及び有機発光素子
JP2010504286A5 (ja)
JP2010529034A5 (ja)
RU2005127626A (ru) Способ получения производных топирамата-антиконвульсантов
RU2009109160A (ru) Инсектицидные изоксазолины
JP2013512915A5 (ja)
JP2010529036A5 (ja)
RU2007148231A (ru) Способ синтеза органических соединений
JP2007532575A5 (ja)
JP2010520851A5 (ja)
JP2008519099A5 (ja)
JP2007502904A5 (ja)
JP2009534504A5 (ja)
JP2004524408A5 (ja)
JP2008189656A5 (ja)
JP2018065817A5 (ja)
JP2007048462A5 (ja)
JP2008247919A5 (ja)
JP2008533169A5 (ja)